Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogunbiyi, O. A.
Right arrow Articles by Kodner, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogunbiyi, O. A.
Right arrow Articles by Kodner, I. J.

Annals of Surgical Oncology, Vol 4, Issue 8 613-620, Copyright © 1997 by Society of Surgical Oncology

ARTICLES

Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography

O. A. Ogunbiyi, F. L. Flanagan, F. Dehdashti, B. A. Siegel, D. D. Trask, E. H. Birnbaum, J. W. Fleshman, T. E. Read, G. W. Philpott and I. J. Kodner
Dept. of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

BACKGROUND: This study evaluates the clinical value of positron emission tomography (PET) with 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) as compared to computed tomography (CT) in patients with suspected recurrent or metastatic colorectal cancer (CRC). METHODS: A retrospective review of the records of 58 patients who had FDG-PET for evaluation of recurrent or advanced primary CRC was performed. FDG-PET results were compared with those of CT and correlated with operative and histopathologic findings, or with clinical course and autopsy reports. RESULTS: Recurrent or advanced primary CRC was diagnosed in 40 and 11 patients, respectively. The sensitivity and specificity of FDG-PET were 91% and 100% for detecting local pelvic recurrence, and 95% and 100% for hepatic metastases. These values were superior to CT, which had sensitivity and specificity of 52% and 80% for detecting pelvic recurrence, and 74% and 85% for hepatic metastases. FDG-PET correctly identified pelvic recurrence in 19 of 21 patients; CT was negative in 6 of these patients and equivocal in 4. FDG-PET was superior to CT in detecting multiple hepatic lesions and influenced clinical management in 10 of 23 (43%) patients. CONCLUSION: FDG-PET is more sensitive than CT in the clinical assessment of patients with recurrent or metastatic CRC, and provides an accurate means of selecting appropriate treatment for these patients.


This article has been cited by other articles:


Home page
 JNMHome page
A. M. Scott, D. H. Gunawardana, B. Kelley, J. G. Stuckey, A. J. Byrne, J. E. Ramshaw, and M. J. Fulham
PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study
J. Nucl. Med., September 1, 2008; 49(9): 1451 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Mahner, S. Schirrmacher, W. Brenner, L. Jenicke, C. R. Habermann, N. Avril, and J. Dose-Schwarz
Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer
Ann. Onc., July 1, 2008; 19(7): 1249 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. S. R. Nahas, T. Akhurst, H. Yeung, E. Riedel, A. J. Markowitz, B. D. Minsky, P. B. Paty, M. R. Weiser, L. K. Temple, W. D. Wong, et al.
Positron Emission Tomography Detection of Distant Metastatic or Synchronous Disease in Patients with Locally Advanced Rectal Cancer Receiving Preoperative Chemoradiation
Ann. Surg. Oncol., March 1, 2008; 15(3): 704 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Wiering, P. F. M. Krabbe, H. M. Dekker, W. J. G. Oyen, and T. J. M. Ruers
The Role of FDG-PET in the Selection of Patients with Colorectal Liver Metastases
Ann. Surg. Oncol., February 1, 2007; 14(2): 771 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips
Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer
Arch Surg, August 1, 2006; 141(8): 783 - 789.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Furukawa, H Ikuma, A Seki, K Yokoe, S Yuen, T Aramaki, and S Yamagushi
Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
Gut, July 1, 2006; 55(7): 1007 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. L. Gearhart, D. Frassica, R. Rosen, M. Choti, R. Schulick, and R. Wahl
Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer
Ann. Surg. Oncol., March 1, 2006; 13(3): 397 - 404.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Lejeune, M. J. Bismuth, T. Conroy, C. Zanni, P. Bey, L. Bedenne, J. Faivre, P. Arveux, and F. Guillemin
Use of a Decision Analysis Model to Assess the Cost-Effectiveness of 18F-FDG PET in the Management of Metachronous Liver Metastases of Colorectal Cancer
J. Nucl. Med., December 1, 2005; 46(12): 2020 - 2028.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. Bipat, M. S. van Leeuwen, E. F. I. Comans, M. E. J. Pijl, P. M. M. Bossuyt, A. H. Zwinderman, and J. Stoker
Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis--Meta-analysis
Radiology, October 1, 2005; 237(1): 123 - 131.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J.-H. Kim, J. Czernin, M. S. Allen-Auerbach, B. S. Halpern, B. J. Fueger, J. R. Hecht, O. Ratib, M. E. Phelps, and W. A. Weber
Comparison Between 18F-FDG PET, In-Line PET/CT, and Software Fusion for Restaging of Recurrent Colorectal Cancer
J. Nucl. Med., April 1, 2005; 46(4): 587 - 595.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D L Francis, A Freeman, D Visvikis, D C Costa, S K Luthra, M Novelli, I Taylor, and P J Ell
In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
Gut, November 1, 2003; 52(11): 1602 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
I. Kantorova, L. Lipska, O. Belohlavek, V. Visokai, M. Trubac, and M. Schneiderova
Routine 18F-FDG PET Preoperative Staging of Colorectal Cancer: Comparison with Conventional Staging and Its Impact on Treatment Decision Making
J. Nucl. Med., November 1, 2003; 44(11): 1784 - 1788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. M. Fayad, C. Cohade, R. L. Wahl, and E. K. Fishman
Sacral Fractures: A Potential Pitfall of FDG Positron Emission Tomography
Am. J. Roentgenol., November 1, 2003; 181(5): 1239 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith
Clinical Role of FDG PET in Evaluation of Cancer Patients
RadioGraphics, March 1, 2003; 23(2): 315 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. C. Desai, E. E. Zervos, M. W. Arnold, W. E. Burak Jr., J. Mantil, and E. W. Martin Jr.
Positron Emission Tomography Affects Surgical Management in Recurrent Colorectal Cancer Patients
Ann. Surg. Oncol., January 1, 2003; 10(1): 59 - 64.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
V. Kalff, R. J. Hicks, R. E. Ware, A. Hogg, D. Binns, and A. F. McKenzie
The Clinical Impact of 18F-FDG PET in Patients with Suspected or Confirmed Recurrence of Colorectal Cancer: A Prospective Study
J. Nucl. Med., April 1, 2002; 43(4): 492 - 499.
[Abstract] [Full Text] [PDF]

Home page
 J. Nucl. Med. Technol.Home page
H. A. Nabi and J. M. Zubeldia
Clinical Applications of 18F-FDG in Oncology
J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
B. Rydzewski, F. Dehdashti, B. A. Gordon, S. A. Teefey, S. M. Strasberg, and B. A. Siegel
Usefulness of Intraoperative Sonography for Revealing Hepatic Metastases from Colorectal Cancer in Patients Selected for Surgery After Undergoing FDG PET
Am. J. Roentgenol., February 1, 2002; 178(2): 353 - 358.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T.J.M. Ruers, B.S. Langenhoff, N. Neeleman, G. J. Jager, S. Strijk, Th. Wobbes, F. H.M. Corstens, and W. J.G. Oyen
Value of Positron Emission Tomography With [F-18]Fluorodeoxyglucose in Patients With Colorectal Liver Metastases: A Prospective Study
J. Clin. Oncol., January 15, 2002; 20(2): 388 - 395.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
W. B. Eubank, D. A. Mankoff, H. J. Vesselle, J. F. Eary, E. K. Schubert, L. K. Dunnwald, S. K. Lindsley, J. R. Gralow, M. M. Austin-Seymour, G. K. Ellis, et al.
Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET
RadioGraphics, January 1, 2002; 22(1): 5 - 17.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
I. A. Zealley, S. J. Skehan, J. Rawlinson, G. Coates, C. Nahmias, and S. Somers
Selection of Patients for Resection of Hepatic Metastases: Improved Detection of Extrahepatic Disease with FDG PET
RadioGraphics, October 1, 2001; 21(90001): S55 - 69.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
S F Barrington
Whole body applications of positron emission tomography in oncology
Imaging, September 1, 2001; 13(3): 185 - 196.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 JNMHome page
J. Meta, M. Seltzer, C. Schiepers, D. H. Silverman, M. Ariannejad, S. S. Gambhir, M. E. Phelps, P. Valk, and J. Czernin
Impact of 18F-FDG PET on Managing Patients with Colorectal Cancer: The Referring Physician's Perspective
J. Nucl. Med., April 1, 2001; 42(4): 586 - 590.
[Abstract] [Full Text]

Home page
 JNMHome page
P. Willkomm, H. Bender, M. Bangard, P. Decker, F. Grunwald, and H.-J. Biersack
FDG PET and Immunoscintigraphy with 99mTc-Labeled Antibody Fragments for Detection of the Recurrence of Colorectal Carcinoma
J. Nucl. Med., October 1, 2000; 41(10): 1657 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. L. Berger, S. A. Nicholson, F. Dehdashti, and B. A. Siegel
FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features
Am. J. Roentgenol., April 1, 2000; 174(4): 1005 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Marom, H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz Jr
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Radiology, September 1, 1999; 212(3): 803 - 809.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society of Surgical Oncology.